Ethics
ADVERSE EVENTS
This study was approved by an ethics committee (Independent Protection Committee 15/026, No. EudraCT 2015–000,401-39) and registered on Clinicantrials.gov as NCT02585388. Patients gave informed consent at the first consultation. The Independent Data Monitoring Committee (IDMC) analyzed interim efficacy data and study-related adverse events.